Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients
Natalia Riva, Jean‐Baptiste Woillard, Maximiliano Distefano, Matias Moragas, Marcelo Dip, Esteban Halac, Paulo Cáceres Guido, Nieves Licciardone, Andrea Mangano, Andrea Bosaleh, María Teresa Davila, Paula Schaiquevich, Oscar Imventarza – 18 May 2019 – Tacrolimus is the cornerstone in pediatric liver transplant immunosuppression. Despite close monitoring, fluctuations in tacrolimus blood levels affect safety and efficacy of immunosuppressive treatments. Identifying the factors related to the variability in tacrolimus exposure may be helpful in tailoring the dose.